Lectins, colitis and colon cancer

Journal of the Royal College of Physicians of London

Volumn 34, Issue 2, 2000, Pages 191-196

  Rhodes, Jonathan M ^a  

^a Clinical Department   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSAMINE; GLYCOPROTEIN; LECTIN;

COLITIS; COLON CANCER; CROHN DISEASE; DIET; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; PATHOGENESIS; PHAGOCYTE; PROTEIN GLYCOSYLATION; REVIEW; ULCERATIVE COLITIS;

COLONIC NEOPLASMS; FOOD HABITS; GLYCOSYLATION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LECTINS; RISK FACTORS;

EID: 0034087314     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:990-6.
2. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996;379:821-3.
3. Satsangi J, Parkes M, Louis E, Hashimoto L, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3,7 and 12. Nat Genet 1996; 14:199-202.
4. Lee JC, Lennard-Jones JE. Inflammatory bowel disease in 67 families each with three or more affected first-degree relatives. Gastroenterology 1996;111:587-96.
5. Myrup B, Valerius NH, Mortensen PB. Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor. Gut 1998;42:127-30.
6. Roe TF, Coates TD, Thomas DW, Miller JH, Gilsanz V. Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type 1b with colony stimulating factors. N Engl J Med 1992;326:1666-9.
7. Segal AW, Shatwell KP. The NADPH oxidase of phagocytic leukocytes. Ann N Y Acad Sci 1997;832:215-22.
8. Segal AW, Loewi G. Neutrophil dysfunction in Crohn's disease. Lancet 1976;ii:219-21.
9. Rhodes JM, Potter BJ, Brown DJ, Jewell DP. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis. Gastroenterology 1982;82:1327-34.
10. Sendid B, Colombel JF, Jacquinto PM, Faille C, et al. Specific antibody response to oligomannoside epitopes in Crohn's disease. Clin Diag Lab Immunol 1996;3:219-26.
11. Zhang K, Petty HR. Influence of polysaccharides on neutrophil function: specific antagonists suggest a model for cooperative saccharide-associated inhibition of immune complex-triggered superoxide production. J Cell Biochem 1994;56:225-35.
12. Vaughan D, Drumm B. Treatment of fistulas with granulocyte colony-stimulating factor in a patient with Crohn's disease. N Engl J Med 1999;340:239-40.
13. O'Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J 1984; 288:1859-62.
14. Beattie RM, Schiffrin EJ, Donnet-Hughes A, Huggett AC, et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 1994;8:609-15.
15. Dickinson RJ, Ashton MG, Axon AT, Smith RC, et al. Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology 1980; 79:1199-204.
16. Fernandez-Banares F, Cabre E, Gonzalez-Huix F, Gassull MA. Enteral nutrition as primary therapy in Crohn's disease. Gut 1994;35(Supp 1):S55-9.
17. Middleton SJ, Rucker JT, Kirby GA, Riordan AM, Hunter JO. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr 1995;14:229-36.
18. Nagel E, Schattenfroh S, Buhner S, Bartels M, et al. Animal experiment studies of ultrastructural changes in the lamina propria of the ileum caused by dietary fats and comparison with cytopathology in Crohn disease. Z Gastroenterol 1993;31:727-34.
19. Powell JJ, Ainley CC, Harvey RS, Mason IM, et al. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 1996;38:390-5.
20. Rhodes JM. Mucins and inflammatory bowel disease. QJ Med 1997; 90:79-82.
21. Clamp JR, Fraser G, Read AE. Study of the carbohydrate content of mucus glycoproteins from normal and diseased colons. Clin Sci 1981;61:229-34.
22. Parker N, Tsai HH, Ryder SD, Raouf AH, Rhodes JM. Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants. Digestion 1995;56:52-6.
23. Raouf AH, Tsai HH, Parker N, Hoffman J, et al. Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis. Clin Sci 1992;83:623-6.
24. Corfield AP, Myerscough N, Bradfield N, Corfield C do A, et al. Colonic mucins in ulcerative colitis: evidence for loss of sulfation. Glycoconj J 1996;13:809-22.
25. Campbell BJ, Finnie IA, Hounsell E, Rhodes JM. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonie adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest 1995;95:571-6.
26. Rhodes JM. Unifying hypothesis for inflammatory bowel disease and related colon cancer: sticking the pieces together with sugar. Lancet 1996;347:40-4.
27. Gyde SN, Prior P, Allan RN, Stevens A, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988;29:206-17.
28. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323:1228-33.
29. Ryder SD, Smith JA, Rhodes JM. Peanut lectin is a mitogen for normal human colonie epithelium and HT29 colorectal cancer cells. J Natl Cancer Inst 1992;84:1410-6.
30. Ryder SD, Smith JA, Rhodes EGH, Rhodes JM. Proliferative responses of HT29 and Caco2 human colorectal cancer cells to a panel of lectins. Gastroenterology 1994;106:85-93.
31. Ryder SD, Parker N, Ecclestone D, Haqqani MT, Rhodes JM. Peanut lectin (PNA) stimulates proliferation in colonic explants from patients with inflammatory bowel disease and colon polyps. Gastroenterology 1994;106:117-24.
32. Ryder SD, Jacyna MR, Levi AJ, Rizzi PM, Rhodes JM. Eating peanuts increases rectal proliferation in individuals with mucosal expression of peanut lectin receptor. Gastroenterology 1998;114:44-9.
33. Yu L, Fernig DG, Smith JA, Milton JD, Rhodes JM. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin. Cancer Res 1993;53:4627-32.
34. Yu L-G, Fernig DG, White MRH, Spiller DG, et al. Edible mushroom (Agaricus bisporus) lectin, which reversibly inhibits epithelial cell proliferation, blocks NLS-dependent nuclear protein import. J Biol Chem 1999;274:4890-9.
35. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998; 76:402-12.
36. Englyst HN, Bingham SA, Runswick SA, Collinson E, Cummings JH. Dietary fibre (non-starch polysaccharides) in fruit, vegetables and nuts. J Hum Nutr Diet 1988;1:247-86.
37. Englyst HN, Bingham SA, Runswick SA, Collinson E, Cummings JH. Dietary fibre (non-starch polysaccharides) in cereal products. J Hum Nutr Diet 1989;2:253-71.
38. Evans RC, Ashby D, Hackett A, Williams E, Rhodes JM. Consumption of peanuts, which contain a galactose-binding lectin, associates with increased risk for colorectal cancer whereas high non-starch polysaccharide galactose intake associates with reduced risk. Gut 1997;41(Suppl 3):A124.